Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study - Bilton, D.; Robinson, P.; Cooper, P.; Gallagher, C.G.; Kolbe, J.; Fox, H.; Jaques, A.; Charlton, B. (The European respiratory journal, 2011)
Keywords: Administration, Inhalation; Adolescent; Biological and medical sciences; Child; Cystic Fibrosis - drug therapy; Cystic Fibrosis - physiopathology; Deoxyribonucleases - therapeutic use; Double-Blind Method; Dry Powder Inhalers; Errors of metabolism; Female; Forced Expiratory Volume; Humans; Male; Mannitol - administration & dosage; Mannitol - adverse effects; Medical sciences; Metabolic diseases; Miscellaneous hereditary metabolic disorders; Pneumology; Recombinant Proteins - therapeutic use; Vital Capacity; Delivery system; clinical study; Respiratory disease; forced expiratory volume in 1 s; Metabolic diseases; Cystic fibrosis; Dry; Clearance; dry powder inhalers; Powder; Genetic disease; Inhalation; Efficiency; Volume; Airway mucociliary clearance; mannitol dry powder; Mannitol; Inhaler; Digestive diseases; Safety; Pancreatic disease; Pneumology